Arena Hayat Danesh

Arena Hayat Danesh is a prominent Iranian biotechnology company specializing in the development and manufacture of recombinant proteins and biosimilars. The company operates as a knowledge-based entity, focusing on high-tech biopharmaceutical production to address critical needs in oncology, hematology, and autoimmune disorders. Its product portfolio includes essential treatments such as Arena-Fil (Filgrastim) and Arena-Poietin (Erythropoietin), which are produced under strict GMP standards. In addition to therapeutics, Arena Hayat Danesh develops molecular diagnostic kits and laboratory reagents for clinical and research applications, including COVID-19 testing solutions. The firm maintains a strong emphasis on research and development, collaborating with academic institutions to advance bioprocess engineering and genetic research. By integrating R&D with large-scale manufacturing, the company aims to provide affordable, high-quality biological medicines to the Middle Eastern market and beyond.